Richtlijn voor diagnostiek en behandeling van de ziekte van Waldenström

Translated title of the contribution: Guidelines for diagnosis and management of Waldenström’s macroglobulinemia

J.M.I. Vos, M.C. Minnema, P.W. Wijermans, S. Croockewit, M.E.D. Chamuleau, S.T. Pals, Saskia Klein, M. Delforge, Gustaaf van Imhoff, M.J. Kersten*

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    305 Downloads (Pure)

    Abstract

    On behalf of the lymphoma and multiple myeloma working parties of the Dutch/Belgian HaematoOncology Foundation for Adults in the Netherlands (HOVON), we present a guideline for diagnosis and management of Waldenström’s macroglobulinemia (WM). Considering the indolent behavior and heterogeneous clinical presentation of WM, it is crucial to determine the right indications for treatment, as well as to individualize therapeutic options. There is a lack of large clinical trials due to the low incidence of WM. Based on the available data, we provide a practical diagnostic classification, as well as recommendations for first line therapy and options for treating relapsed disease.
    Translated title of the contributionGuidelines for diagnosis and management of Waldenström’s macroglobulinemia
    Original languageDutch
    Pages (from-to)219–231
    Number of pages13
    JournalNederlands Tijdschrift voor Hematologie
    Volume9
    Issue number6
    Publication statusPublished - Sept-2012

    Fingerprint

    Dive into the research topics of 'Guidelines for diagnosis and management of Waldenström’s macroglobulinemia'. Together they form a unique fingerprint.

    Cite this